foxo4-dri peptide senolytic human trial trials Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging Buy FOXO4-DRI (Proxofim) FOXO4-DRI: Human Trial Status, Cancer
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4





















